MYDAYIS FDA approval date
The FDA approved MYDAYIS on 20 Jun 2017.
- FDA approval date
- 20 Jun 2017
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2017-06-20Day | MYDAYIS | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA022063", "applicant_as_listed_by_fda": "TAKEDA PHARMS USA", "brand_names": ["MYDAYIS"], "active_ingredients": ["AMPHETAMINE ASPARTATE", "AMPHETAMINE SULFATE", "DEXTROAMPHETAMINE SACCHARATE", "DEXTROAMPHETAMINE SULFATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170620", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |